Literature DB >> 13870089

Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883).

S BLOM.   

Abstract

Entities:  

Keywords:  ANTICONVULSANTS/therapy; TRIGEMINAL NEURALGIA/therapy

Mesh:

Substances:

Year:  1962        PMID: 13870089     DOI: 10.1016/s0140-6736(62)91847-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  49 in total

Review 1.  Pharmacological management of neuropathic pain.

Authors:  Gary McCleane
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  TO-DAY'S DRUGS: CARBAMAZEPINE.

Authors:  R GER
Journal:  Br Med J       Date:  1964-08-01

3.  Interaction of carbamazepine and other drugs with adenosine (A1 and A2) receptors.

Authors:  Y Fujiwara; M Sato; S Otsuki
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  [Not Available].

Authors:  U Thoden
Journal:  Schmerz       Date:  1992-03       Impact factor: 1.107

Review 5.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 6.  Central pain.

Authors:  L S Illis
Journal:  BMJ       Date:  1990-05-19

7.  Treatment of tic douloureux with a new anticonvulsant (clonazepam).

Authors:  J E Court; C S Kase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-03       Impact factor: 10.154

8.  Surgical treatment of trigeminal neuralgia.

Authors: 
Journal:  Br Med J       Date:  1977-09-17

Review 9.  Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.

Authors:  R I Henkin
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

10.  Effects of carbamazepine and anti-depressant drugs on endogenous catecholamine levels in the cerebroventricular compartment of the rat.

Authors:  S Kowalik; M Levitt; A I Barkai
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.